Kommentar in Demming, A. “Editorial: Nanodevices come to life” Nanotechnology 22 (2011) 090201 (2pp). Radtke, K., Kieneke, D., Wolfstein, A., Michael, K., Steffen, W., Scholz, T., Karger, A., Sodeik, B. (2010) [...] 102070. Amrute-Nayak, M., Nayak, A., Steffen, W., Tsiavaliaris, G., Scholz, T., Brenner, B. (2019) Transformation of the non-processive fast skeletal myosin II into a processive motor. Small. Jan 18:e1804313 [...] 18:e1804313. Doi: 10.1002/smll.201804313. Behrens, V.A., Walter, W.J., Peters, C., Wang, T, Brenner, B., Geeves, M.A., Scholz, T.*, Steffen, W.* (2018) Mg2+-free ATP regulates native cytoplasmic dynein’s

Viktor, U. Keilholz, A. Boehm, O. Guntinas-Lichius, B. Hennemann, H. J. Schmoll, P. Ivanyi, M. Abbas, U. Lehmann, A. Koch , A. Karch , A. Zörner, and T. C. Gauler. 2015. “TEMHEAD: A Single-Arm Multicentre [...] Mice.” Bone Marrow Transplantation 51(4):596–97. Wacker, M. E., R. A. Jörres, H. Schulz, J. Heinrich, S. Karrasch, A. Karch , A. Koch , A. Peters, R. Leidl, C. Vogelmeier, and R. Holle. 2016. “Direct and [...] B., A. Großhennig , M. Homs, B. Heidrich, A. Erhardt, K. Deterding, J. Jaroszewicz, B. Bremer, A. Koch , M. Cornberg, M. P. Manns, M. Buti, and H. Wedemeyer. 2014. “Development and Evaluation of a Bas

and Q&A rounds. The trainer Dr. Martina Michalikova has a background in biology and computational neuroscience. She is a certified writing consultant specialized in scientific writing in English as a second [...] Please bring to the course: your own recent research result in form of a figure, table or equation. Alternatively a figure from a published, recently read paper and also one page of their own text for [...] individual coaching can be booked as a follow up to the workshop. (Cost will be covered by your research network.) The trainer Gaby Schilling holds a PhD in chemistry and a BSc. in psychology. She worked for

cord blood (CB) transplant, a solid organ transplant or a transplant from a virus-seronegative donor no T-cell donor will be available. For this reason, a rapid recruitment of a respective T-cell donor and [...] authorities was granted by March 27th, 2014. If you have a patient, who is in need of a third party T-cell donor from alloCELL registry and/or a personalized antiviral T-cell immunotherapeutics monitoring [...] and an established method for a fast manufacturing of antiviral T cells without long-term ex vivo culture are of great importance. A registry of potential third-party T-cell donors (allogeneic cell registry

NM, Hoffmann D, Maetzig T, Ballmaier M, Godinho T, Cathomen T, Schambach A. Cytometry A. 2015 May;87(5):405-18. doi: 10.1002/cyto.a.22650. Epub 2015 Feb 27. PMID: 25728583 High frequencies of polyfunctional [...] Tiemann U, Sgodda M, Warlich E, Ballmaier M, Schöler HR, Schambach A, Cantz T. Cytometry A. 2011 Jun;79(6):426-35. doi: 10.1002/cyto.a.21072. Epub 2011 May 4. PMID: 21548079 Acute-phase protein α1-antitrypsin [...] against HCMV. Theobald SJ, Kreer C, Khailaie S, Bonifacius A, Eiz-Vesper B, Figueiredo C, Mach M, Backovic M, Ballmaier M, Koenig J, Olbrich H, Schneider A, Volk V, Danisch S, Gieselmann L, Ercanoglu MS, Messerle

program consists of a three-year research project as well as taught seminars and the attendance of congresses and practical courses . Not only does the student have the opportunity to work on a long-term research [...] on the critical presentation of a wide range of papers and reviews from the most relevant journals in the field of infection biology. The presentations are held in a weekly tutorial which all students [...] students attend. Each student is required to present an original paper and a research topic based on a review. The topic of the original paper is always related to the general field of the student's research

Katzka, C., Rai, A., Wolf, A., Brockmeyer, A., Janning, P., Reubold, T.F. , Eschenburg, S., Manstein, D.J., Hübel, K., Kaiser, M., Waldmann, H. (2009) The Ras pathway modulator melophlin A targets dynamins [...] cleft: functional characterisation of myosin II with a strut mutation. J. Muscle Res. Cell Motil. 27 , 115-123. Reubold, T.F. , Eschenburg, S., Becker, A., Leonard, M., Schmid, S.L., Vallee, R.B., Kull, F [...] Natl. Acad. Sci. USA 102 , 13093-13098. Reubold, T.F. , Eschenburg, S., Becker, A., Kull, F.J., Manstein, D.J. (2003). A structural model for actin-induced nucleotide release in myosin. Nat. Struct. Biol

Phys Rehabil Med 2017; 53: 308-318 Kröz M, Reif M, Glinz A, Berger B, Nikolau A, Zerm R, Brinkhaus B, Girke M, Büssing A, Gutenbrunner C. Impact of a combined Multimodal-Aerobic and Multimodal Intervention [...] Cancer-Related Fatigue - Results of a Three-armed Pragmatic Trial in a Comprehensive Cohort Design. BMC Cancer 2017; 17: 166-178 Lohss R, Blumenthal M, Gottschling-Lang A, Egen C, Gutenbrunner C, Sturm C [...] Tederko P, Nugraha B. Responding to the WHO Global Disability Action Plan in Ukraine: A Technical Consultancy to develop a National Disability, Health and Rehabilitation Plan. J Rehabil Med 2017; 50: doi:

Brettschneider C, Damm O, Freytag A, Greiner W, Icks A, König HH, Krauth C , Kuhlmann A, Kunigkeit C, Montalbo J, Mostardt S, Mühlbacher A, Neumann A, Neusser S, Plagemann T, Schwalm A, Ultsch B, Wasem J, Witte [...] Brinkmann M , Dulovic A, Gornyk D, Hovardovska O, Kuczewski C, Kurosinski M-A, Schlotz M, Schneiderhan-Marra N, Strengert M, Krause G, Sester M, Klein F, Petersmann A, Karch A, Lange B (2024). Bridging [...] Brinkmann M , Dulovic A, Gornyk D, Hovardovska O, Kuczewski C, Kurosinski M-A, Schlotz M, Schneiderhan-Marra N, Strengert M, Krause G, Sester M, Klein F, Petersmann A, Karch A, Lange B (2023). Bridging

botulinum neurotoxin A substrate binding pockets and their re-engineering for human SNAP-23. J Mol Biol 428 , 372-384. PubMed-Link Pirazzini M, Henke T, Rossetto O, Mahrhold S, Krez N, Rummel A, Montecucco C [...] PubMed-Link Willjes G, Mahrhold S, Strotmeier J, Eichner T, Rummel A, Binz T (2013): Botulinum neurotoxin G binds synaptotagmin-II in a mode similar to that of serotype B: tyrosine 1186 and lysine 1191 [...] Immunol 364 , 139-157. Review PubMed-Link Strotmeier J, Willjes G, Binz T, Rummel A (2012): Human synaptotagmin-II is not a high affinity receptor for botulinum neurotoxin B and G: increased therapeutic dosage